Cargando…

BIRC3 is a novel driver of therapeutic resistance in Glioblastoma

Genome-wide analysis of glioblastoma (GBM) reveals pervasive aberrations in apoptotic signaling pathways that collectively contribute to therapeutic resistance. Inhibitors of apoptosis proteins (IAP) exert critical control on the terminal segment of apoptosis leading to apoptosis evasion. In this st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Dapeng, Berglund, Anders, Kenchappa, Rajappa S., Forsyth, Peter A., Mulé, James J., Etame, Arnold B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757860/ https://www.ncbi.nlm.nih.gov/pubmed/26888114 http://dx.doi.org/10.1038/srep21710

Ejemplares similares

BIRC3 is a biomarker of mesenchymal habitat of glioblastoma, and a mediator of survival adaptation in hypoxia-driven glioblastoma habitats
por: Wang, Dapeng, et al.
Publicado: (2017)

A Novel Role of BIRC3 in Stemness Reprogramming of Glioblastoma
por: Wu, Qiong, et al.
Publicado: (2021)

Paradoxical epigenetic regulation of XAF1 mediates plasticity towards adaptive resistance evolution in MGMT-methylated glioblastoma
por: Wu, Qiong, et al.
Publicado: (2019)

The Impact of Epigenetic Modifications on Adaptive Resistance Evolution in Glioblastoma
por: Wu, Qiong, et al.
Publicado: (2021)

LPTO-03. IN-VITRO & IN-VIVO CULTURE OF PATIENT (PT) DERIVED CSF-CTCs IN LEPTOMENINGEAL DISEASE (LMDz) FROM MELANOMA TO IDENTIFY NOVEL TREATMENT STRATEGIES
por: Law, Vincent, et al.
Publicado: (2019)

Epigenetic Activation of TUSC3 Sensitizes Glioblastoma to Temozolomide Independent of MGMT Promoter Methylation Status
por: Wu, Qiong, et al.
Publicado: (2023)

BIRC3 and BIRC5: multi‐faceted inhibitors in cancer
por: Frazzi, Raffaele
Publicado: (2021)

Differential regulation of BIRC2 and BIRC3 expression by inflammatory cytokines and glucocorticoids in pulmonary epithelial cells
por: Thorne, Andrew, et al.
Publicado: (2023)

Oncogenic activity of BIRC2 and BIRC3 mutants independent of nuclear factor-κB-activating potential
por: Yamato, Azusa, et al.
Publicado: (2015)

Activation of STAT3 through combined SRC and EGFR signaling drives resistance to a mitotic kinesin inhibitor in glioblastoma
por: Kenchappa, Rajappa S., et al.
Publicado: (2022)

Increased Expression of BIRC2, BIRC3, and BIRC5 from the IAP Family in Mesenchymal Stem Cells of the Umbilical Cord Wharton's Jelly (WJSC) in Younger Women Giving Birth Naturally
por: Gil-Kulik, Paulina, et al.
Publicado: (2020)

BIRC6 mediates imatinib resistance independently of Mcl-1
por: Okumu, Denis O., et al.
Publicado: (2017)

Gene Network Revealed Involvements of Birc2, Birc3 and Tnfrsf1a in Anti-Apoptosis of Injured Peripheral Nerves
por: Wang, Yongjun, et al.
Publicado: (2012)

Identification of BIRC6 as a novel intervention target for neuroblastoma therapy
por: Lamers, Fieke, et al.
Publicado: (2012)

BIRC2–BIRC3 amplification: a potentially druggable feature of a subset of head and neck cancers in patients with Fanconi anemia
por: Roohollahi, Khashayar, et al.
Publicado: (2022)

Protein kinase C(ι) and SRC signaling define reciprocally related subgroups of glioblastoma with distinct therapeutic vulnerabilities
por: Kenchappa, Rajappa S., et al.
Publicado: (2021)

Publisher Correction: BIRC2–BIRC3 amplification: a potentially druggable feature of a subset of head and neck cancers in patients with Fanconi anemia
por: Roohollahi, Khashayar, et al.
Publicado: (2022)

The Prognostic and Therapeutic Implications of the Chemoresistance Gene BIRC5 in Triple-Negative Breast Cancer
por: Adinew, Getinet M., et al.
Publicado: (2022)

Regulation of Anti-Apoptotic SOD2 and BIRC3 in Periodontal Cells and Tissues
por: Rath-Deschner, Birgit, et al.
Publicado: (2021)

Bioinformatics analysis of BIRC5 in human cancers
por: Ye, Han-Bin, et al.
Publicado: (2022)

TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients
por: Piro, G, et al.
Publicado: (2015)

Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia
por: Diop, Fary, et al.
Publicado: (2020)

Exploration of induced sputum BIRC3 levels and clinical implications in asthma
por: Du, Lijuan, et al.
Publicado: (2022)

Enhancing Brain Retention of a KIF11 Inhibitor Significantly Improves its Efficacy in a Mouse Model of Glioblastoma
por: Gampa, Gautham, et al.
Publicado: (2020)

Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma
por: Pace, Angelica, et al.
Publicado: (2022)

BIRC6 Is Associated with Vulnerability of Carotid Atherosclerotic Plaque
por: Alloza, Iraide, et al.
Publicado: (2020)

BIRC7 is Beneficial for Melanoma Progression and Hypoxic Response
por: Xu, Haiting, et al.
Publicado: (2022)

BIRC3 alterations in chronic and B-cell acute lymphocytic leukemia patients
por: ALHOURANI, EYAD, et al.
Publicado: (2016)

Identification of ARNT-regulated BIRC3 as the target factor in cadmium renal toxicity
por: Lee, Jin-Yong, et al.
Publicado: (2017)

Snail Promotes Cancer Cell Proliferation via Its Interaction with the BIRC3
por: Rho, Seung Bae, et al.
Publicado: (2022)

Improving Brain Metastases Outcomes Through Therapeutic Synergy Between Stereotactic Radiosurgery and Targeted Cancer Therapies
por: Rubino, Sebastian, et al.
Publicado: (2022)

Cul4 E3 ubiquitin ligase regulates ovarian cancer drug resistance by targeting the antiapoptotic protein BIRC3
por: Hu, Xiaoyan, et al.
Publicado: (2019)

Pan-cancer analysis identifies BIRC5 as a prognostic biomarker
por: Fäldt Beding, Anna, et al.
Publicado: (2022)

The BIRC6 gene as a novel target for therapy of prostate cancer: dual targeting of inhibitors of apoptosis
por: Iris Luk, Sze Ue, et al.
Publicado: (2014)

H. pylori infection confers resistance to apoptosis via Brd4-dependent BIRC3 eRNA synthesis
por: Chen, Yanheng, et al.
Publicado: (2020)

BIRC6 modifies risk of invasive bacterial infection in Kenyan children
por: Gilchrist, James J, et al.
Publicado: (2022)

miR-30e Blocks Autophagy and Acts Synergistically with Proanthocyanidin for Inhibition of AVEN and BIRC6 to Increase Apoptosis in Glioblastoma Stem Cells and Glioblastoma SNB19 Cells
por: Chakrabarti, Mrinmay, et al.
Publicado: (2016)

Metabolic Drivers of Invasion in Glioblastoma
por: Garcia, Joseph H., et al.
Publicado: (2021)

Myosin 10 Regulates Invasion, Mitosis, and Metabolic Signaling in Glioblastoma
por: Kenchappa, Rajappa S., et al.
Publicado: (2020)

Analysis of the inhibitors of apoptosis identifies BIRC3 as a facilitator of malignant progression in glioma
por: Gressot, Loyola V., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hv60e01tpvbfs3isp4pddg6rs1